Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-03-13
1982-05-11
Fagelson, Anna P.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 422 57, 424 12, 424 85, 424 88, 435 4, 435 7, 435 30, 435258, 435947, G01N 3354, G01N 3358, C12Q 100, C12R 190
Patent
active
043293310
ABSTRACT:
Systemic lupus erythematosus is diagnosed by contacting the blood serum of a patient with anaplasma antigen derived from a vertebrate infected by an organism of the genus Anaplasmataceae and thereafter contacting the antigen with an indicator for human immunoglobulin components.
REFERENCES:
Kallick, Arth. and Rheum., vol. 23, Feb. 1980, pp. 197-205.
Kallick, Nature, New Biol., vol. 236, Apr. 5, 1972, pp. 145-146.
LandOfFree
Diagnostic method for detection of systemic lupus erythematosus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Diagnostic method for detection of systemic lupus erythematosus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Diagnostic method for detection of systemic lupus erythematosus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-755728